Damage to myelin by oxidative stress is seen in disorders such as AD with cognitive impairment.[30] In the present study, treatment with ezetimibe significantly improved STZ-induced memory deficits along with attenuation of STZ-induced rise in brain AChE activity and brain oxidative stress levels. The gene discussed is ACHE; the disease is Alzheimer disease.